Rockefeller Capital Management
MIRM icon

Rockefeller Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Rockefeller Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$572K Buy
4,888
+17
+0.3% +$1.71K ﹤0.01% 2016
2026
Q1 		$450K Buy
4,871
+3,189
+190% +$300K ﹤0.01% 2028
2025
Q4 		$133K Buy
1,682
+1,158
+221% +$83.1K ﹤0.01% 2574
2025
Q3 		$38.4K Buy
+524
New +$33.3K ﹤0.01% 3036

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rockefeller Capital Management's MIRM Position: Q2 2026 in Review

Rockefeller Capital Management increased its Mirum Pharmaceuticals (MIRM) stake by 0.35% in Q2 2026, buying an estimated $1.71K and bringing the position to 4,888 shares worth $572K. The position accounts for ﹤0.01% of the portfolio, ranked #2016.

Rockefeller Capital Management first reported a position in MIRM in Q3 2025 and has held it in 4 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Rockefeller Capital Management held 4,888 shares of Mirum Pharmaceuticals worth $572K as of Q2 2026.
  • Rockefeller Capital Management bought 17 Mirum Pharmaceuticals shares in Q2 2026, an estimated $1.71K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #2016 holding.
  • Rockefeller Capital Management first reported a position in Mirum Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.